[go: up one dir, main page]

CS160591A3 - Quinazoline derivatives, process for their manufacture and their application as medicaments - Google Patents

Quinazoline derivatives, process for their manufacture and their application as medicaments Download PDF

Info

Publication number
CS160591A3
CS160591A3 CS911605A CS160591A CS160591A3 CS 160591 A3 CS160591 A3 CS 160591A3 CS 911605 A CS911605 A CS 911605A CS 160591 A CS160591 A CS 160591A CS 160591 A3 CS160591 A3 CS 160591A3
Authority
CS
Czechoslovakia
Prior art keywords
group
carbon atoms
amino
methyl
formula
Prior art date
Application number
CS911605A
Other languages
Czech (cs)
English (en)
Inventor
Robert George Andrew
Andrew John Barker
Francis Thomas Boyle
James Michael Wardleworth
Original Assignee
Ici Plc
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10676728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CS160591(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ici Plc, Nat Res Dev filed Critical Ici Plc
Publication of CS160591A3 publication Critical patent/CS160591A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS911605A 1990-05-30 1991-05-29 Quinazoline derivatives, process for their manufacture and their application as medicaments CS160591A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9011989 1990-05-30

Publications (1)

Publication Number Publication Date
CS160591A3 true CS160591A3 (en) 1992-01-15

Family

ID=10676728

Family Applications (1)

Application Number Title Priority Date Filing Date
CS911605A CS160591A3 (en) 1990-05-30 1991-05-29 Quinazoline derivatives, process for their manufacture and their application as medicaments

Country Status (15)

Country Link
US (1) US5280027A (fi)
EP (1) EP0459730A3 (fi)
JP (1) JPH04235173A (fi)
AU (1) AU640016B2 (fi)
CA (1) CA2042922A1 (fi)
CS (1) CS160591A3 (fi)
FI (1) FI912600A (fi)
GB (1) GB2244708B (fi)
HU (1) HUT57739A (fi)
IE (1) IE64085B1 (fi)
IL (1) IL98167A0 (fi)
NO (1) NO912071L (fi)
NZ (1) NZ238259A (fi)
PT (1) PT97799A (fi)
ZA (1) ZA913730B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9220571D0 (en) * 1992-09-30 1992-11-11 Ici Plc Quinazoline derivatives
CA2230082C (en) 1995-08-22 2005-07-05 Japan Tobacco Inc. Amide compounds and use thereof
ATE212632T1 (de) * 1995-09-08 2002-02-15 Univ Princeton Nicht-klassische antifolate
GB9904275D0 (en) * 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US6518292B1 (en) * 1999-03-12 2003-02-11 Bristol-Myers Squibb Co. Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) * 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6753428B2 (en) * 2001-11-20 2004-06-22 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
JP2005529076A (ja) * 2002-02-15 2005-09-29 サイトキネティクス・インコーポレーテッド キナゾリノンの合成
US7214800B2 (en) 2002-05-09 2007-05-08 Cytokinetics, Inc. Compounds, compositions, and methods
MXPA04011074A (es) * 2002-05-09 2005-06-08 Cytokinetics Inc Compuestos de pirimidinona, composiciones y metodos.
US7038048B2 (en) * 2002-05-23 2006-05-02 Cytokinetics, Inc. 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
CA2489367A1 (en) * 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
AU2003256805A1 (en) * 2002-07-23 2004-02-09 Cytokinetics, Inc. Compounds compositions and methods
WO2004018058A2 (en) * 2002-08-21 2004-03-04 Cytokinetics, Inc. Compounds, compositions, and methods
AU2003277079A1 (en) 2002-09-30 2004-05-04 Cytokinetics, Inc. Compounds, compositions, and methods
US20050197327A1 (en) * 2003-11-03 2005-09-08 Gustave Bergnes Compounds, compositions, and methods
JP2007510660A (ja) * 2003-11-07 2007-04-26 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
JP2007513154A (ja) * 2003-12-08 2007-05-24 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
CN101801937A (zh) * 2007-06-22 2010-08-11 艾科尔公司 喹唑啉酮化合物及其使用方法
DE102010001064A1 (de) * 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
JP2014527511A (ja) 2011-06-24 2014-10-16 アムジエン・インコーポレーテツド Ｔｒｐｍ８拮抗剤及び治療におけるそれらの使用
JP2014517074A (ja) 2011-06-24 2014-07-17 アムジエン・インコーポレーテツド Ｔｒｐｍ８アンタゴニストおよび治療におけるそれらの使用
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
US10413583B2 (en) * 2016-11-30 2019-09-17 The University Of Chicago Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods
US20250026763A1 (en) * 2023-05-25 2025-01-23 Allorion Therapeutics Inc Egfr inhibitors and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds

Also Published As

Publication number Publication date
GB2244708A (en) 1991-12-11
AU640016B2 (en) 1993-08-12
PT97799A (pt) 1992-02-28
GB9111656D0 (en) 1991-07-24
NZ238259A (en) 1993-07-27
JPH04235173A (ja) 1992-08-24
AU7707591A (en) 1991-12-05
IE64085B1 (en) 1995-07-12
IL98167A0 (en) 1992-06-21
FI912600A (fi) 1991-12-01
CA2042922A1 (en) 1991-12-01
GB2244708B (en) 1993-12-08
NO912071D0 (no) 1991-05-29
HUT57739A (en) 1991-12-30
NO912071L (no) 1991-12-02
EP0459730A3 (en) 1993-01-20
EP0459730A2 (en) 1991-12-04
US5280027A (en) 1994-01-18
ZA913730B (en) 1992-02-26
FI912600A0 (fi) 1991-05-30
IE911757A1 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
CS160591A3 (en) Quinazoline derivatives, process for their manufacture and their application as medicaments
CA2702647C (en) Thiopyrimidine-based compounds and uses thereof
CA3030510C (en) Azole dione compounds with anti-cancer activity
US9446034B2 (en) Pyrazolylaminopyridines as inhibitors of FAK
US20100298557A1 (en) Pyrazolopyrimidine compound
IE61566B1 (en) Anti-tumour 4-oxoquinazoline derivatives
EP3621615B1 (en) Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
RU2111209C1 (ru) Производные хиназолина, способ их получения и фармацевтическая композиция на их основе
ES2773693T3 (es) Derivados de cianoquinolina
WO2010072166A1 (zh) 二氢化茚酰胺化合物制备方法、包含其的药物组合物、及其作为蛋白激酶抑制剂的应用
WO2023274251A1 (zh) 一类抑制rna解旋酶dhx33的多环化合物及其应用
TW200916447A (en) Sirtuin inhibitors
WO2019012172A1 (es) Nuevos derivados heteroaryl amida como inhibidores selectivos de histona deacetilasa 1 y 2 (hdac1/2)
WO2012014221A1 (en) Substituted 4-(4-fluoro-3-(piperazine-1- carbonyl)benzyl)phthalazin-1(2h)-one derivatives as poly (adp-ribose) polymerase- 1 inhibitors
KR20210053911A (ko) Ahr 조절제로서의 헤테로사이클릭 화합물
CN105705493A (zh) 喹唑啉衍生物、其制备方法、药物组合物和应用
WO2011131135A1 (zh) 芳杂（烷基）氨基二硫代甲酸酯类化合物、其制备方法和应用
WO2016140501A1 (en) Pyridine n-oxide for enhancer of zeste homolog 2 inhibitors
AU772670B2 (en) Anti-cancer dihydroquinazoline derivatives
WO2005080392A1 (ja) ピラゾロキノロン誘導体およびその用途
GB2217709A (en) Anti-tumour 4-oxoquinazolines
CN105384738A (zh) 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途
US10351540B2 (en) 1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions
AU2022411461A1 (en) Pyrimidine or pyridine derivative and medicinal use thereof
CN117567473A (zh) 一种靶向同源二聚体的抑制剂及其制备方法与应用